Home › FDA seeks expert input on ideal patient group for experimental cholesterol-lowering drug
 

Keywords :   


FDA seeks expert input on ideal patient group for experimental cholesterol-lowering drug

2015-06-08 17:44:34| Biotech - Topix.net

Federal health regulators say a highly-anticipated, experimental drug from Amgen significantly lowers bad cholesterol. But officials have questions about who should take the drug and whether to approve it based on currently available data.

Tags: group drug ideal expert

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09This Week in Agribusiness, September 28, 2024
28.09This Week in Agribusiness, September 28, 2024
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
28.09Post-Tropical Cyclone Helene Graphics
28.09Post-Tropical Cyclone Helene Public Advisory Number 20
28.09Hurricane Isaac Graphics
More »